Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.29 | 7e-07 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-06 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-05 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.29 | 4e-05 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-05 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |